Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 30, 2025 • 4:21 PM ET

Date/Time Source News Release
04/29/2025 09:05 AM EDT GlobeNewswire Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting
04/24/2025 07:55 AM EDT GlobeNewswire Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025
04/16/2025 07:00 AM EDT GlobeNewswire Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025
04/09/2025 07:00 AM EDT GlobeNewswire Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix's Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana's Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies
04/07/2025 07:00 AM EDT GlobeNewswire Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting
04/02/2025 07:00 AM EDT GlobeNewswire Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference
04/01/2025 07:00 AM EDT GlobeNewswire Tonix Pharmaceuticals Launches TONIX ONE(TM), a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition
03/31/2025 07:00 AM EDT ACCESS Newswire Tonix's Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year
03/27/2025 07:00 AM EDT GlobeNewswire Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting
03/24/2025 08:00 AM EDT GlobeNewswire Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia
Page

Additional News

As of April 30, 2025 • 4:21 PM ET

Date/Time Source News Release
04/29/2025 10:10 AM EDT InvestorBrandNetwork BioMedNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Preclinical Data for TNX-1700 at AACR 2025
04/24/2025 09:45 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Showcases Single-Dose Mpox Vaccine Data at World Vaccine Congress
04/16/2025 09:28 AM EDT InvestorBrandNetwork BioMedNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at World Vaccine Congress Washington 2025
04/09/2025 09:15 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Collaborates With Makana Therapeutics on Xenotransplantation Research
04/07/2025 09:05 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Data on Fibromyalgia Drug at AAPM 2025
04/07/2025 12:02 AM EDT Stock Traders Daily (TNXP) Investment Analysis
04/02/2025 09:25 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) CEO to Present at 2025 Jones Trading Healthcare Conference
04/01/2025 09:15 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Launches TONIX ONE(TM) Digital Platform to Transform Migraine Care
03/31/2025 11:01 AM EDT InvestorBrandNetwork BioMedNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Advances Non-Opioid Fibromyalgia Drug Toward FDA Decision
03/27/2025 10:26 AM EDT InvestorBrandNetwork BioMedNewsBreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at AAPM 2025 PainConnect Meeting 
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.